The Delaware senator wants a say in the next director of the U.S. Patent and Trademark Office, and claims to have a deal with the White House.
vaccines
Posted inTAP
Back From Hell
Today on TAP: Now that quasi-normal is back, let’s take time to appreciate it
Posted inTAP
The Vaccine Waiver Invites Reform of Intellectual-Property Abuses
Today on TAP: The patent system no longer works to promote and reward invention
Posted inCoronavirus
Will Biden Favor Drug Companies—or Billions of People Needing COVID Vaccines?
As the global humanitarian crisis deepens, so far the U.S. government is siding with Big Pharma.
Posted inFirst 100
First 100: Biden Finally Agrees that Pandemics Are Global
Help to India on the way. Plus: movement on health care.
Posted inMoney, Politics, and Power
Place Human Lives Over Pharma’s Property Rights
The Biden administration is divided over whether to waive trade protections for Big Pharma—with Commerce Secretary Gina Raimondo as a key industry ally.
Posted inFirst 100
First 100: Where’s the Michigan Vaccine Surge?
Plus, more executive action options to lower drug prices.
Posted inFirst 100
First 100: The Case for Vaccine Passports
We’re in a health emergency and they can stop the spread.
Posted inMoney, Politics, and Power
Toward a Conflict-of-Interest-Free West Wing
Incomplete disclosures from Biden’s staff raise as many questions as they answer.
Posted inFirst 100
First 100: Your Questions About Biden and the Pandemic, Answered
Plus, more Congressional Review Act resolutions released.
